dr. luciano rossetti on the function of anti-pd-l1 treatments in bladder cancer
Published 8 years ago • 322 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
3:27
improving anti-pd-1/pd-l1 therapy for localized bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
2:26
pd-l1 immunotherapy in bladder cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
7:06
pd-l1 in metastatic bladder cancer - bladder cancer video library
-
7:55
pd-l1 expression in bladder cancer
-
3:36
anti-pd-l1 immunotherapy with mpdl3280a in metastatic bladder cancer
-
1:08
future treatment approaches for patients with bladder cancer
-
1:26
impact of immunotherapy on bladder cancer
-
1:32
utility of pd-l1 as a biomarker in bladder cancer
-
2:50
the evolution of pd-l1 immunotherapy for bladder cancer
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
1:47
dr. siefker-radtke on pd-l1 as a biomarker in bladder cancer
-
1:06
the mechanism of action of durvalumab in the treatment of urothelial bladder cancer
-
1:07
exploring the role of biomarkers in patient selection for immunotherapy in bladder cancer
-
1:28
chemoimmunotherapy for bladder cancer: similarties to lung cancer